News
Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...
Morning Overview on MSN5d
The first AI-generated drug enters clinical trials
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...
Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...
Makary announced plans for a new rare disease pathway in an April episode of "The Megyn Kelly Show." The proposal follows ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
Generative AI, once seen as a tool for writers and artists, is now reshaping the high-stakes world of pharma regulation.
Ori Biotech’s CEO said the prioritization of review by FDA, coupled to the impact of the technology, could shave up to three ...
2d
News Medical on MSNReal-time Raman monitoring for pharmaceutical hot melt extrusion
Nimesh Khadka: Hot melt extrusion is widely used to improve drug solubility, bioavailability, and stability, but the process ...
The amendments will also enable the central drug regulator—Central Drugs Standard Control Organisation (CDSCO)—to optimise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results